BioCentury | Nov 10, 2020
Finance

Nov. 9 Quick Takes: Biogen sheds $14B in value; plus Ambrx’s 200M round, Decibel’s series D and more

...converted into a pivotal trial.Inmagene adds $21M in series BShanghai-based Inmagene Biopharmaceuticals Co. Ltd. said Vertex Ventures China...
Items per page:
1 - 1 of 1
BioCentury | Nov 10, 2020
Finance

Nov. 9 Quick Takes: Biogen sheds $14B in value; plus Ambrx’s 200M round, Decibel’s series D and more

...converted into a pivotal trial.Inmagene adds $21M in series BShanghai-based Inmagene Biopharmaceuticals Co. Ltd. said Vertex Ventures China...
Items per page:
1 - 1 of 1